Active Bones, Joints & Muscles

Neuro-immune interactions in chronic joint pain: how T cell subsets might affect persistent nociception in inflammatory arthritis

In plain English

AI plain-English summary

Inflammatory arthritis leaves many patients with persistent joint pain even after standard treatments have brought their inflammation under control. This PhD project will investigate whether regulatory T cells—immune cells that normally dampen inflammation—are directly interacting with sensory neurons in the joint and either helping or hindering pain signalling. Current treatments focus on reducing inflammation, but they often fail to resolve the pain that remains. The problem is that scientists do not yet understand how anti-inflammatory signals from T cells affect the nerve endings that detect pain. This project will map those interactions by combining computer-based predictions with lab experiments using patient-derived cells and a mouse model of arthritis. If the research identifies specific ligand-receptor pairs between T cell subsets and sensory neurons, those molecules could become new drug targets for pain relief that works independently of inflammation control. This would address a major unmet need: the millions of arthritis patients whose quality of life is limited by pain that existing therapies cannot touch. The work is fundamental science, but it targets a concrete clinical gap with a clear path toward therapeutic development.

View original technical description
Improved standard of care has alleviated the inflammatory burden for many patients with inflammatory arthritis (IA). However, the remaining pain and tenderness still impact patients’ quality of life. While pro-inflammatory mediators can induce neuronal hyperactivity in the joint, the effect of anti- inflammatory mediators released from cells like regulatory T cells on sensory neurons has not been sufficiently investigated. This PhD project will investigate direct and indirect interactions between sensory neurons and regulatory T cells/ other T cell subsets in the joint in IA. An in-silico ligand-receptor interaction analysis will be matched with in vitro approaches verifying the identified interactions using synovial fluid T cell subsets and iPSC derived sensory neurons. Next, potential modulation of identified interactions by IA therapeutics will be analysed. In addition, iPSC derived neurons will be grown through microfluidic chambers, separating cell body and nerve endings to mimic the conditions in vivo. An IA mouse model will be used to ensure translatability of the findings. We anticipate identifying ligand- receptor interactions between different T cell subsets and sensory neurons. Information on how these interactions affect nociception will help reveal new potential therapeutic targets to tackle pain in IA.

View the original record at the funder ↗

Researchers

Katja Freytag (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Reducing the persistent pain of juvenile arthritis: a targeted translational approach
MICA: Synovial fibroblast pain pathotypes: A roadmap to understanding and targeting the complexity of patient-reported joint pain in osteoarthritis
Targeting the NaV1.7 Interactome for Pain Relief in Arthritis
MICA: Exosomes and microRNAs regulate neuro-immune interactions in chronic pain
Manipulation of monocytes/macrophages for the control of arthritis pain using pro-resolving lipid mediators and blockade of CX3CR1 receptor

Original classification

PhD Studentship (Basic)

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.